AU1468901A - Quinoline and naphthyridine carboxylic acid antibacterials - Google Patents

Quinoline and naphthyridine carboxylic acid antibacterials Download PDF

Info

Publication number
AU1468901A
AU1468901A AU14689/01A AU1468901A AU1468901A AU 1468901 A AU1468901 A AU 1468901A AU 14689/01 A AU14689/01 A AU 14689/01A AU 1468901 A AU1468901 A AU 1468901A AU 1468901 A AU1468901 A AU 1468901A
Authority
AU
Australia
Prior art keywords
oxo
dihydro
cyclopropyl
methoxy
benzothien
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU14689/01A
Other languages
English (en)
Inventor
David D. Anderson
Curt S Cooper
Jurgen Dinges
Pamela L. Donner
Steven W Elmore
Brian E. Green
Douglas K Hutchinson
Linda M. Lynch
Colleen C. Schultz
Qinghua Xie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of AU1468901A publication Critical patent/AU1468901A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AU14689/01A 1999-11-05 2000-11-06 Quinoline and naphthyridine carboxylic acid antibacterials Abandoned AU1468901A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US43529799A 1999-11-05 1999-11-05
US09435297 1999-11-05
US70533200A 2000-11-03 2000-11-03
US09705332 2000-11-03
PCT/US2000/030551 WO2001032655A2 (en) 1999-11-05 2000-11-06 Quinoline and naphthyridine carboxylic acid antibacterials

Publications (1)

Publication Number Publication Date
AU1468901A true AU1468901A (en) 2001-05-14

Family

ID=27030507

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14689/01A Abandoned AU1468901A (en) 1999-11-05 2000-11-06 Quinoline and naphthyridine carboxylic acid antibacterials

Country Status (12)

Country Link
EP (1) EP1226146A2 (ja)
JP (1) JP2003524633A (ja)
AR (1) AR030537A1 (ja)
AU (1) AU1468901A (ja)
BG (1) BG106679A (ja)
BR (1) BR0010728A (ja)
CZ (1) CZ20021531A3 (ja)
HK (1) HK1047287A1 (ja)
IL (1) IL148738A0 (ja)
MX (1) MXPA02004474A (ja)
NO (1) NO20022156L (ja)
WO (1) WO2001032655A2 (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002018345A1 (en) * 2000-08-29 2002-03-07 Chiron Corporation Quinoline antibacterial compounds and methods of use thereof
CA2445591A1 (en) 2001-04-27 2002-11-07 The Procter & Gamble Company Nitrogen heterocyclic compounds and compositions for controlling biofilms
US8163769B2 (en) 2002-03-12 2012-04-24 Abbott Laboratories Antibacterial compounds
JP2006514964A (ja) * 2003-03-12 2006-05-18 アボット・ラボラトリーズ 抗菌剤としてのナフチリジン誘導体
EP1829869A1 (en) 2006-03-02 2007-09-05 Laboratorios Del Dr. Esteve, S.A. 4,5,6,7-Tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands
US20080139574A1 (en) 2006-11-30 2008-06-12 Cadila Healthcare Limited Novel quinoline derivatives
TWI498115B (zh) * 2007-12-27 2015-09-01 Daiichi Sankyo Co Ltd 咪唑羰基化合物
BR122021013836B1 (pt) 2009-12-04 2022-05-24 Sunovion Pharmaceuticals, Inc. Composto e seu uso, composição farmacêutica
MX2019000980A (es) 2016-07-29 2019-07-04 Sunovion Pharmaceuticals Inc Compuestos y composiciones y usos de los mismos.
JP2019523279A (ja) 2016-07-29 2019-08-22 サノビオン ファーマシューティカルズ インクＳｕｎｏｖｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． 化合物および組成物ならびにそれらの使用
JP7146782B2 (ja) 2017-02-16 2022-10-04 サノビオン ファーマシューティカルズ インク 統合失調症を処置する方法
MX2020000523A (es) 2017-08-02 2020-08-20 Sunovion Pharmaceuticals Inc Compuestos de isocromano y usos de los mismos.
CN118406063A (zh) 2018-02-16 2024-07-30 赛诺维信制药公司 盐、晶型及其制备方法
US11136304B2 (en) 2019-03-14 2021-10-05 Sunovion Pharmaceuticals Inc. Salts of a heterocyclic compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof
MX2022012833A (es) 2020-04-14 2022-11-07 Sunovion Pharmaceuticals Inc (s)-(4,5-dihidro-7h-tieno[2,3-c]piran-7-il)-n-metilmetanamina para tratar trastornos neurologicos y psiquiatricos.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents

Also Published As

Publication number Publication date
NO20022156D0 (no) 2002-05-06
BG106679A (bg) 2003-01-31
JP2003524633A (ja) 2003-08-19
NO20022156L (no) 2002-07-04
IL148738A0 (en) 2002-09-12
MXPA02004474A (es) 2002-11-07
HK1047287A1 (zh) 2003-02-14
AR030537A1 (es) 2003-08-27
BR0010728A (pt) 2004-02-17
CZ20021531A3 (cs) 2002-09-11
EP1226146A2 (en) 2002-07-31
WO2001032655A2 (en) 2001-05-10
WO2001032655A3 (en) 2002-01-24

Similar Documents

Publication Publication Date Title
AU1468901A (en) Quinoline and naphthyridine carboxylic acid antibacterials
DE69020676T2 (de) Tricyclische Carbapenemverbindungen.
JP4058106B2 (ja) 抗菌性のピペリジン誘導体
US20020049223A1 (en) Quinoline and naphthyridine carboxylic acid antibacterials
AU2003248592B2 (en) Biaryl diazabicycloalkane amides as nicotinic acetylcholine agonists
DE602004008945T2 (de) Thienopyrrole als antivirale mittel
CA2250002C (en) Cephem compounds and drugs containing the compounds
US20050277633A1 (en) Spiro-rifamycin derivatives targeting RNA polymerase
JP2008542249A (ja) 抗細菌活性を持つアミノピペリジンキノリン及びそのアザ等立体類似体
JPH01100174A (ja) 抗緑内障剤としての置換芳香族スルホンアミド類
BG62404B1 (bg) Бензоксазолилови и бензотиазолилови оксазолидинони,метод за тяхното получаване и приложението им като лекарствени средства
AU2004312193A1 (en) Thiophene derivatives as CHK 1 inihibitors
AU2004267052B2 (en) Isothiazoloquinolones and related compounds as anti-infective agents
AU2006214234B2 (en) New isothiazoloquinolones and related compounds as anti-infective agents
EP2051974A1 (en) Tetrahydrobenzothiophene derivatives
US8163769B2 (en) Antibacterial compounds
KR100195345B1 (ko) 신규 피리도[2,3-f][1,4]티아제핀 및 피리도[3,2-b][1,5]벤조티아제핀
WO2004083207A1 (en) Naphthyridine derivatives as antibacterial agents
EP0596125A1 (en) Condensed thiophene compound and pharmaceutical use thereof
DE3688066T2 (de) 1-carbacephalosporin-antibiotika.
MX2007005731A (es) 8a, 9-dihidro-4a-h-isotiazolo [5,4-b] quinolina-3, 4-diomas y compuestos relacionados como agentes anti-infeccion.
DE69706321T2 (de) Cephemderivate
Okada et al. Synthesis and antibacterial activities of novel oxazine and thiazine ring‐fused tricyclic quinolonecarboxylic acids: 10‐(Alicyclic amino)‐9‐fluoro‐7‐oxo‐7H‐pyrido [1, 2, 3‐de][1, 4] benzoxazine‐6‐carboxylic acids and the corresponding 1‐thia congeners

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period